---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-100985"
form_type: "8-K"
ticker: "IXHL"
cik: "0001873875"
company_name: "Incannex Healthcare Inc."
filed_at: "2025-10-22T23:59:59+00:00"
generated_at: "2026-05-17T02:49:12.547463+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Incannex gets 180-day Nasdaq extension to April 20, 2026 for bid price compliance

## Summary
- Nasdaq granted Incannex until April 20, 2026 to maintain $1.00 closing bid for 10 consecutive days.
- Extension follows Incannex meeting all other listing criteria and providing reverse stock split intent.
- CEO notes two Phase 2 clinical data packages delivered in 2025 and strong cash position.
- Company will monitor share price and take actions to regain compliance within the extension period.

## SEC filing metadata
- accession: 0001213900-25-100985
- form_type: 8-K
- ticker: IXHL
- cik: 0001873875
- company_name: Incannex Healthcare Inc.
- filed_at: 2025-10-22T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1873875/000121390025100985/0001213900-25-100985-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1873875/000121390025100985/ea0262073-8k_incannex.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-100985
- JSON: https://secwatch.observer/filing/0001213900-25-100985.json
- Plain text: https://secwatch.observer/filing/0001213900-25-100985.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.